ASEP Medical Holdings Inc.
ASEP
CNSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.29% | -1.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.29% | -1.46% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 1.29% | -1.46% | |||
| SG&A Expenses | -51.32% | 54.75% | |||
| Depreciation & Amortization | 0.00% | -1.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -40.38% | 41.73% | |||
| Operating Income | 42.82% | -45.44% | |||
| Income Before Tax | 27.60% | -40.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.60% | -40.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 8.49% | 22.17% | |||
| Net Income | 34.44% | -45.12% | |||
| EBIT | 42.82% | -45.44% | |||
| EBITDA | 57.48% | -73.62% | |||
| EPS Basic | 35.19% | -42.11% | |||
| Normalized Basic EPS | 40.00% | -46.34% | |||
| EPS Diluted | 35.19% | -42.11% | |||
| Normalized Diluted EPS | 40.00% | -46.34% | |||
| Average Basic Shares Outstanding | 0.42% | 1.92% | |||
| Average Diluted Shares Outstanding | 0.42% | 1.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
